Market Closed -
Bombay S.E.
11:00:53 28/06/2024 BST
|
5-day change
|
1st Jan Change
|
58.25
INR
|
-1.10%
|
|
-7.11%
|
-28.46%
|
Fiscal Period: March |
2022
|
2023
|
---|
Capitalization
1 |
439.3
|
381.7
|
Enterprise Value (EV)
1 |
523.3
|
686.2
|
P/E ratio
|
6.62
x
|
30.5
x
|
Yield
|
2.1%
|
-
|
Capitalization / Revenue
|
229,785
x
|
179,783
x
|
EV / Revenue
|
273,707
x
|
323,255
x
|
EV / EBITDA
|
3,950,777
x
|
8,581,424
x
|
EV / FCF
|
4,369,242
x
|
-2,649,236
x
|
FCF Yield
|
0%
|
-0%
|
Price to Book
|
1.32
x
|
1.13
x
|
Nbr of stocks (in thousands)
|
9,219
|
9,219
|
Reference price
2 |
47.65
|
41.40
|
Announcement Date
|
05/09/22
|
05/09/23
|
Fiscal Period: March |
2020
|
2021
|
2022
|
2023
|
---|
Net sales
|
-
|
2,435
|
1,912
|
2,123
|
EBITDA
|
-
|
81.57
|
132.4
|
79.97
|
EBIT
1 |
-0.111
|
63.5
|
112.3
|
56.24
|
Operating Margin
|
-
|
2.61%
|
5.87%
|
2.65%
|
Earnings before Tax (EBT)
1 |
-0.111
|
40.58
|
93.46
|
20.3
|
Net income
1 |
-0.111
|
17.8
|
66.39
|
12.52
|
Net margin
|
-
|
0.73%
|
3.47%
|
0.59%
|
EPS
2 |
-0.2708
|
1.931
|
7.201
|
1.359
|
Free Cash Flow
|
-
|
-141.1
|
119.8
|
-259
|
FCF margin
|
-
|
-5.8%
|
6.26%
|
-12.2%
|
FCF Conversion (EBITDA)
|
-
|
-
|
90.42%
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
180.4%
|
-
|
Dividend per Share
|
-
|
-
|
1.000
|
-
|
Announcement Date
|
16/11/20
|
07/09/21
|
05/09/22
|
05/09/23
|
Fiscal Period: March |
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
104
|
84
|
305
|
Net Cash position
1 |
0.04
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
1.271
x
|
0.634
x
|
3.809
x
|
Free Cash Flow
|
-
|
-141
|
120
|
-259
|
ROE (net income / shareholders' equity)
|
-
|
13.2%
|
22.2%
|
3.74%
|
ROA (Net income/ Total Assets)
|
-
|
7.27%
|
5.79%
|
2.82%
|
Assets
1 |
-
|
244.8
|
1,146
|
443.9
|
Book Value Per Share
2 |
9.730
|
28.90
|
36.00
|
36.50
|
Cash Flow per Share
2 |
0.0900
|
2.280
|
19.70
|
0.6800
|
Capex
|
-
|
-
|
-
|
76.3
|
Capex / Sales
|
-
|
-
|
-
|
3.6%
|
Announcement Date
|
16/11/20
|
07/09/21
|
05/09/22
|
05/09/23
|
|
1st Jan change
|
Capi.
|
---|
| +55.32% | 815B | | -6.75% | 352B | | +13.56% | 314B | | +10.68% | 303B | | +16.57% | 242B | | +2.04% | 224B | | +13.31% | 218B | | +8.48% | 168B | | -2.81% | 159B |
Other Pharmaceuticals
|